NEWS COMMENTARY

Redefine Meat, developer of 3D printers for plant-based meats, raises $6 million seed round

Published:
September 16, 2019
Coverage:
Emerging Ecosystems in Agrifood and Health More...
Activities:
Investment
by Thomas Hayes
Ignore

CPT Capital led the round, with Germany poultry company PHW Group also participating. Redefine Meat (formerly Jet-Eat) will use the funding to complete the development of its 3D printer system, scheduled for release in 2020. This comes within a week of the funding announcement for NovaMeat. Redefine Meat and NovaMeat are two of the three developers specifically targeting 3D printers for plant-based meats; the other is SavorEat. Much like 3D printing of food in general, this approach is only suitable for low-volume/high-value applications. Given that 3D printing of plant-based meats is essentially a niche within a niche, we do not recommend that clients engage with this space.

For the original news article, click here .


Further Reading

Israeli startup Yofix raises $2.5 million funding for plant-based dairy

News Commentary | February 14, 2020

This funding round was led by a set of new investors, including the venture arm of German group Mueller and French cheese supplier Bel Group. Yofix (Lux Take: Monitor) produces fermented plant‑based dairy alternatives made from oats, lentils, and other grains. With this funding, the company looks to... Not part of subscription

Legacy plant-based meat maker Growthwell of Singapore receives $8 million in funding

News Commentary | April 28, 2020

Temasek, which has been a major funder to Impossible Foods, led the round. The funds will be used to establish an R&D center by Q1 2021 and take an equity stake in Israeli startup ChickP. Growthwell also plans to develop both meat and dairy substitutes using ChickP's 90% chickpea protein isolate... Not part of subscription

Mycoproteins gain funding momentum as The Protein Brewery raises $22 million Series A

News Commentary | November 12, 2020

This Series A round was led by Novo Holdings, joined by Roquette Ventures and Unovis Asset Management, and will help the Dutch startup to focus on R&D as well as scale up production of its mycoprotein ingredient "Fermotein." It hopes to commercialize Fermotein upon regulatory approval by 2021 in... To read more, click here.